Vivani Medical announces 1st GLP-1 implant in Liberate-1 clinical trial
Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...
The Ozempic workout? How gyms and trainers are catering to a new group of exercisers
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
Medscape4h
How to Guide Your Patients With Obesity to Optimize Health
Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.
Healio16h
Optimal timing for cessation of GLP-1 receptor agonists prior to TJA may be 14 days
Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...
Employers face pressure to add coverage of Ozempic, other weight-loss drugs
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Stopping GLP-1 RAs 14 days before surgery can minimize complications
Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...
Becker's Hospital Review1d
GLP-1s reshape key service lines: What to know
Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.
Becker's ASC2d
GLP-1s and total joint replacement: 10 things to know
"Concerns arise over GLP-1 use during major surgeries like joint replacements. A study reveals optimal timing for stopping Ozempic to reduce anesthesia risks." ...
Becker's Spine Review2d
Ceasing Ozempic before joint replacements: 7 things to know
"Discover the latest findings on GLP-1s and orthopedic care, including the recommended timeline for stopping Ozempic before joint replacement surgery, to reduce ...